Exclusive

Publication

Byline

Access to obesity management not available to most Indian patients: World Heart Federation report

Mumbai, May 18 -- Obesity in India has risen tremendously in the last 35 years, in tandem with rising rates across the world, a new report highlights, and tools to manage obesity are not universally a... Read More


US tailwinds, AI investments, to drive growth for IKS Health

New Delhi, May 16 -- Jhunjhunwala family-backed Inventurus Knowledge Solutions (IKS) aims to grow faster than the market in FY26 with more investments in artificial intelligence (AI), improving synerg... Read More


Piramal Pharma to see muted CDMO growth on US jitters; strong recovery in FY27

New Delhi, May 15 -- Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clien... Read More


Piramal Pharma CDMO growth hit by US policy jitters; recovery seen in FY27

New Delhi, May 15 -- Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clien... Read More


Don't expect immediate impact of US tariff threat, price cuts on business, says Cipla head

New Delhi, May 13 -- Cipla does not expect any immediate impact from potential tariffs imposed by the US on pharmaceutical imports or from US President Trump's recent order to bring down prescription ... Read More


Biocon sees mid-teens revenue growth on biosimilars, generics push

New Delhi, May 13 -- Biocon Ltd expects its overall revenue to grow in mid-teens this financial year, and the company is betting on a robust launch pipeline in its generics as well as biosimilars busi... Read More


Biocon to evaluate merger with subsidiary Biologics

New Delhi, May 12 -- Biocon Group's board is setting up a committee to evaluate strategic restructuring options, including a merger of its biosimilars arm Biocon Biologics Ltd with its flagship Biocon... Read More


Trump's planned drug price cuts trigger decline in share prices: Will Indian pharma be impacted?

New Delhi, May 12 -- Shares of Indian pharmaceutical companies plunged close to 6% on Monday after US President Donald Trump proposed sweeping price cuts on prescription drugs and pharma prices in the... Read More


Dr. Reddy's focused on securing supply chains amid US tariff uncertainty

New Delhi, May 9 -- Amid growing concerns about potential US import tariffs on pharmaceuticals, Indian generics giant Dr. Reddy's Laboratories is taking steps to secure its supply chain for key produc... Read More


Bain Capital-owned Indian chemicals firm eyes US expansion after key acquisition

New Delhi, May 8 -- Novopor Advanced Science Pvt. Ltd, a Bain Capital portfolio company manufacturing specialty chemicals, is looking to expand its footprint in the US after chalking up its first acqu... Read More